TELO (Telomir Pharmaceuticals, Inc.) Rega marang bathi mangsa ngarep

Simbol resmi perusahaan Telomir Pharmaceuticals, Inc. (TELO)

Telomir Pharmaceuticals (TELO) is in the early stages of research, remaining insulated from market cycles. A forward P/E ratio chart for the company is available in the GURU.Markets system, where 0.00 represents the current metric. Success in telomere-based rejuvenation will ensure absolute pricing power, while breakthrough small molecule developments will enable the halting of aging processes.

telomirpharma.com - Rasio kapitalisasi marang bathi mangsa ngarep TELO (periode 21.02.2024 - 17.11.2026)

Ringkesan rincian data analitis telomirpharma.com (TELO)

- rega saiki lan proyeksi nilai saham:
Produk merek Telomir Pharmaceuticals

To find fundamental support for Telomir Pharmaceuticals (TELO) shares, it is essential to consider the diversification of research into telomeric compounds aimed at combating age-related pathologies. By analyzing the company's future P/E trajectory, an investor compares current market capitalization with expected annual earnings, which allows for an assessment of the asset's overbought status and the determination of a safe entry volume to avoid risking price destabilization.

Pesaing wigati

Rega marang bathi mangsa ngarep haleon.com (HLN)|KVUE (Kenvue Health) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|Amneal - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech Corp - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi glpg.com GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Rasio rega marang bathi sing dikarepake|SPRY - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi TBPH (Theravance Biopharma)|AQST (aquestive.com) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake SCPH (scPharmaceuticals, Inc.)|Prakiraan rega marang bathi TECX|Tonix Pharmaceuticals (TNXP) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SXTC|Pangali Forward P/E Eupraxia Pharma (EPRX)|Rega marang bathi mangsa ngarep BioHarvest Sciences Inc. BHST|EXOZ - Prakiraan rega marang bathi|ORMP: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi abvcpharma.com (ABVC)|Rega marang bathi mangsa ngarep Cumberland Pharma|Rega marang bathi mangsa ngarep QNTM|Pangali Forward P/E FGEN|Pangali Forward P/E Rani Therapeutics Holdings (RANI)|Pangali Forward P/E SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Rasio prakiraan rega marang bathi|LEXX - Rega marang bathi mangsa ngarep|PULM (Pulmatrix) - Rasio rega marang bathi mangsa ngarep|Pheton Holdings Ltd (PTHL) - Rega marang bathi mangsa ngarep|Aptorum - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi LYRA|Prakiraan rega marang bathi Impact BioMedical Inc (IBO)|Pangali Forward P/E TNFA|YCBD: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep PainReform PRFX|altamiratherapeutics.com (CYTO) - Rasio prakiraan rega marang bathi|LIPO: Prakiraan rega marang bathi|OPTN (optinose.com) - Rasio rega marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|PTPI (Petros Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep QLI|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP